KPC Pharmaceuticals,Inc 600422.SS Stock
KPC Pharmaceuticals,Inc Price Chart
KPC Pharmaceuticals,Inc 600422.SS Financial and Trading Overview
| KPC Pharmaceuticals,Inc stock price | 21.92 CNY |
| Previous Close | 21.86 CNY |
| Open | 21.84 CNY |
| Bid | 21.81 CNY x 0 |
| Ask | 21.82 CNY x 0 |
| Day's Range | 21.73 - 22.49 CNY |
| 52 Week Range | 10.7 - 26.09 CNY |
| Volume | 16.83M CNY |
| Avg. Volume | 14.21M CNY |
| Market Cap | 16.54B CNY |
| Beta (5Y Monthly) | 0.563351 |
| PE Ratio (TTM) | 42.784313 |
| EPS (TTM) | 0.59 CNY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 30, 2022 |
| 1y Target Est | 23.43 CNY |
600422.SS Valuation Measures
| Enterprise Value | 16.5B CNY |
| Trailing P/E | 42.784313 |
| Forward P/E | 22.265305 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.113099 |
| Price/Book (mrq) | 3.234989 |
| Enterprise Value/Revenue | 2.108 |
| Enterprise Value/EBITDA | 26.916 |
Trading Information
KPC Pharmaceuticals,Inc Stock Price History
| Beta (5Y Monthly) | 0.563351 |
| 52-Week Change | 76.00% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 26.09 CNY |
| 52 Week Low | 10.7 CNY |
| 50-Day Moving Average | 21.74 CNY |
| 200-Day Moving Average | 17.11 CNY |
600422.SS Share Statistics
| Avg. Volume (3 month) | 14.21M CNY |
| Avg. Daily Volume (10-Days) | 13.89M CNY |
| Shares Outstanding | 758.13M |
| Float | 464.4M |
| Short Ratio | N/A |
| % Held by Insiders | 43.13% |
| % Held by Institutions | 11.86% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.16 |
| Trailing Annual Dividend Yield | 0.73% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.5094 |
| Last Split Factor | 20:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 5.10% |
| Operating Margin (ttm) | 5.61% |
| Gross Margin | 43.70% |
| EBITDA Margin | 7.82% |
Management Effectiveness
| Return on Assets (ttm) | 3.00% |
| Return on Equity (ttm) | 7.79% |
Income Statement
| Revenue (ttm) | 7.83B CNY |
| Revenue Per Share (ttm) | 10.39 CNY |
| Quarterly Revenue Growth (yoy) | -19.19% |
| Gross Profit (ttm) | N/A |
| EBITDA | 612.99M CNY |
| Net Income Avi to Common (ttm) | 399.74M CNY |
| Diluted EPS (ttm) | 0.51 |
| Quarterly Earnings Growth (yoy) | 14.49% |
Balance Sheet
| Total Cash (mrq) | 1.28B CNY |
| Total Cash Per Share (mrq) | 1.69 CNY |
| Total Debt (mrq) | 862.83M CNY |
| Total Debt/Equity (mrq) | 16.37 CNY |
| Current Ratio (mrq) | 1.841 |
| Book Value Per Share (mrq) | 6.745 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 38.23M CNY |
| Levered Free Cash Flow (ttm) | 69.69M CNY |
Profile of KPC Pharmaceuticals,Inc
| Country | China |
| State | N/A |
| City | Kunming |
| Address | No.166 Keyi Road |
| ZIP | 650106 |
| Phone | 86 871 6831 9868 |
| Website | https://www.kpc.com.cn |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 5322 |
KPC Pharmaceuticals, Inc, a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People's Republic of China and internationally. It offers artemether, panax notoginseng, and gastrodine series drugs, as well as Chinese medicines and ethnic drugs under the Luotai, Tianxuanqing, Artemedine, Artem, and Arco brand names for treating cardio-cerebral-vascular and nervous system diseases, as well as malaria. The company also provides Dai medicines; antibiotics, chemical medicinal raw materials, chemical pharmaceutical preparations, traditional Chinese medicinal materials, biological products, biochemical drugs, and health foods; Amoxicillin, Cefaclor, Alfacalcidol, Artz, Snaplets, and Ribavirin spray products; glycyrrhizic acid; and GLP-1, a long-acting hypoglycemic drug. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. The company was founded in 1951 and is based in Kunming, the People's Republic of China.
Q&A For KPC Pharmaceuticals,Inc Stock
What is a current 600422.SS stock price?
KPC Pharmaceuticals,Inc 600422.SS stock price today per share is 21.92 CNY.
How to purchase KPC Pharmaceuticals,Inc stock?
You can buy 600422.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for KPC Pharmaceuticals,Inc?
The stock symbol or ticker of KPC Pharmaceuticals,Inc is 600422.SS.
Which industry does the KPC Pharmaceuticals,Inc company belong to?
The KPC Pharmaceuticals,Inc industry is Drug Manufacturers-Specialty & Generic.
How many shares does KPC Pharmaceuticals,Inc have in circulation?
The max supply of KPC Pharmaceuticals,Inc shares is 757.11M.
What is KPC Pharmaceuticals,Inc Price to Earnings Ratio (PE Ratio)?
KPC Pharmaceuticals,Inc PE Ratio is 37.15254600 now.
What was KPC Pharmaceuticals,Inc earnings per share over the trailing 12 months (TTM)?
KPC Pharmaceuticals,Inc EPS is 0.59 CNY over the trailing 12 months.
Which sector does the KPC Pharmaceuticals,Inc company belong to?
The KPC Pharmaceuticals,Inc sector is Healthcare.